Tsukahara, Y.; Ferran, B.; Minetti, E.T.; Chong, B.S.H.; Gower, A.C.; Bachschmid, M.M.; Matsui, R.
Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. Antioxidants 2022, 11, 867.
https://doi.org/10.3390/antiox11050867
AMA Style
Tsukahara Y, Ferran B, Minetti ET, Chong BSH, Gower AC, Bachschmid MM, Matsui R.
Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. Antioxidants. 2022; 11(5):867.
https://doi.org/10.3390/antiox11050867
Chicago/Turabian Style
Tsukahara, Yuko, Beatriz Ferran, Erika T. Minetti, Brian S. H. Chong, Adam C. Gower, Markus M. Bachschmid, and Reiko Matsui.
2022. "Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis" Antioxidants 11, no. 5: 867.
https://doi.org/10.3390/antiox11050867
APA Style
Tsukahara, Y., Ferran, B., Minetti, E. T., Chong, B. S. H., Gower, A. C., Bachschmid, M. M., & Matsui, R.
(2022). Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis. Antioxidants, 11(5), 867.
https://doi.org/10.3390/antiox11050867